ArticleCNS drugs2022

Authors' Reply to Pappagallo et al.: Comment on "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status".

Ioline D Henter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.